BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25850259)

  • 21. Formulation and evaluation of mefenamic acid sustained release matrix pellets.
    Ibrahim MA
    Acta Pharm; 2013 Mar; 63(1):85-98. PubMed ID: 23482315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on the formulation and process of Da Chuan Xiong Fang pellet by extrusion-spheronization].
    Hong YL; Feng Y; Xu DS; Jiang LH; Yang Y
    Zhong Yao Cai; 2007 Dec; 30(12):1596-600. PubMed ID: 18422197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of formulations for the preparation of pellets with high drug loading by extrusion/spheronization.
    Podczeck F; Knight P
    Pharm Dev Technol; 2006; 11(3):263-74. PubMed ID: 16895837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Influence of superfine grinding on micromeritic properties of Scutellaria baicalensis].
    Wang NM; Zhang DK; Yang M; Qin CF; Han L; Su ZT; Guo ZP
    Zhong Yao Cai; 2013 Apr; 36(4):640-4. PubMed ID: 24134013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of kappa-carrageenan as alternative pelletisation aid to microcrystalline cellulose in extrusion/spheronisation. II. Influence of drug and filler type.
    Thommes M; Kleinebudde P
    Eur J Pharm Biopharm; 2006 May; 63(1):68-75. PubMed ID: 16325384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of microcrystalline cellulose grade on shape and shape distributions of pellets produced by extrusion-spheronization.
    Koo OM; Heng PW
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1383-7. PubMed ID: 11724226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of two kinds of methods to prepare Chinese medicine Danggui Buxue formula pellets].
    Chen HX; Jia XB; Fan CY; Shi YF; Wei HH
    Zhongguo Zhong Yao Za Zhi; 2008 Dec; 33(24):2908-10. PubMed ID: 19294847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mechanism of "unification of drugs and excipients" for Chinese medicine semi-extract based on powder compression behavior analysis].
    Wang F; Xu B; Zhang KF; Yang MR; Tang ZX; Lu Y; Qiao YJ
    Zhongguo Zhong Yao Za Zhi; 2020 Jan; 45(2):274-284. PubMed ID: 32237309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies on new co-processed excipient consisting of lactose and gelatinized starch].
    Wang ST; Zhang J; Lin X; Shen L; Feng Y
    Zhongguo Zhong Yao Za Zhi; 2014 Nov; 39(22):4329-34. PubMed ID: 25850261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in characteristics of pellets prepared by different pelletization methods.
    Häring A; Vetchý D; Janovská L; Krejcová K; Rabisková M
    Drug Dev Ind Pharm; 2008 Mar; 34(3):289-96. PubMed ID: 18363144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extrusion/spheronization--effect of moisture content and spheronization time on pellet characteristics.
    Iyer RM; Augsburger LL; Pope DG; Shah RD
    Pharm Dev Technol; 1996 Dec; 1(4):325-31. PubMed ID: 9552316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research of preparation craft of Danshen phenolic acid fast release unit in multi-drug delivery system of Tongmai micro-pellets].
    Chen B; Xiao W; Jia XB; Huang Y
    Zhong Yao Cai; 2012 Jul; 35(7):1140-3. PubMed ID: 23252282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study on preparation of Qixian decoction pellets in tangential spray fluid bed].
    Luo X; Zhang G; Huang F; Rao X; He Y; Hu P
    Zhongguo Zhong Yao Za Zhi; 2009 Mar; 34(6):690-3. PubMed ID: 19624005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functionality of cross-linked polyvinylpyrrolidone as a spheronization aid: a promising alternative to microcrystalline cellulose.
    Liew CV; Gu L; Soh JL; Heng PW
    Pharm Res; 2005 Aug; 22(8):1387-98. PubMed ID: 16078149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the performance of a new continuous spheronizer.
    Pinto JF; Abreu CN
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1067-78. PubMed ID: 17012119
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Roller compaction of moist pharmaceutical powders.
    Wu CY; Hung WL; Miguélez-Morán AM; Gururajan B; Seville JP
    Int J Pharm; 2010 May; 391(1-2):90-7. PubMed ID: 20176096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and characterization of pellets using Avicel CL611 as spheronization aid.
    Puah SY; Yap HN; Chaw CS
    Drug Dev Ind Pharm; 2014 Mar; 40(3):418-24. PubMed ID: 23480532
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combining experimental design and orthogonal projections to latent structures to study the influence of microcrystalline cellulose properties on roll compaction.
    Dumarey M; Wikström H; Fransson M; Sparén A; Tajarobi P; Josefson M; Trygg J
    Int J Pharm; 2011 Sep; 416(1):110-9. PubMed ID: 21708239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of powdered cellulose for the production of pellets by extrusion/spheronization.
    Lindner H; Kleinebudde P
    J Pharm Pharmacol; 1994 Jan; 46(1):2-7. PubMed ID: 8201523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.